Clinical Utility of Oxford Cognitive Screen Test to Screen Cognitive Impairment in Post Stroke Patients
Launched by BUNDANG CHA HOSPITAL · Mar 31, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a tool called the Korean version of the Oxford Cognitive Screen (K-OCS) to see how well it can identify cognitive problems in patients who have had a stroke. The researchers want to ensure that this tool is reliable and accurate, meaning it should correctly detect issues while not giving false alarms. They are also comparing how many patients agree to take part in this test compared to other existing assessments.
To participate in this study, you need to be an adult over 20 years old who has had a stroke at least 72 hours prior. You will be asked to give your consent after understanding what the study involves. Healthy volunteers who are also over 20 and live independently can join the study as well. Participants can expect to undergo a series of assessments related to their cognitive function, helping researchers improve future care for stroke patients.
Gender
ALL
Eligibility criteria
- • For stroke patients
- 1. Inclusion Criteria:
- • Adults over 20 years of age
- • More than 72 hours elapsed since the onset of stroke symptoms.
- • After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions
- • Involved individuals diagnosed with stroke by neurology and rehabilitation medicine specialists based on data acquired from 3T GE Signa System (General Electric, Milwaukee, WI), brain magnetic resonance imaging (MRI), and computed tomography (CT).
- 2. Exclusion Criteria:
- • Who cannot meet the inclusion criteria
- • For healthy voluteers
- 1. Inclusion Criteria:
- • Over 20 years of age
- • A person who is performing an independent daily life
- • A person who voluntarily decides to participate and agrees in writing to abide by the precautions after hearing a detailed explanation of this study and fully understanding it
- 2. Exclusion Criteria:
- • Who cannot meet the inclusion criteria
About Bundang Cha Hospital
Bundang CHA Hospital is a leading healthcare institution located in South Korea, renowned for its commitment to innovative medical research and patient-centered care. As a prominent clinical trial sponsor, the hospital leverages its advanced facilities and multidisciplinary expertise to conduct rigorous clinical studies across various therapeutic areas. With a focus on advancing medical knowledge and improving treatment outcomes, Bundang CHA Hospital collaborates with a network of esteemed researchers and healthcare professionals to ensure the highest standards of clinical excellence and ethical practices in all its trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam Si, Gyeonggi Do, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported